Business Context and Reporting Period
InfuSystem Holdings, Inc. filed a Form 8-K Current Report on July 21, 2011. The filing discloses a material amendment to the company's existing credit agreement.
Key Financial Metrics
This filing does not provide specific financial metrics such as revenue, profit, cash flow, margins, or total debt levels. The document focuses exclusively on the modification of debt covenants.
Material Changes
On July 21, 2011, InfuSystem Holdings, Inc., InfuSystem, Inc., and First Biomedical, Inc. (the "Borrowers") entered into a Fourth Amendment to their Credit Agreement dated June 15, 2010. The lenders involved are Bank of America, N.A. (Administrative Agent and Lender) and Keybank National Association (Lender). The amendment specifically modified the covenants restricting capital expenditures and capital leases entered into by the Borrowers and their subsidiaries.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed beyond the execution of the credit agreement amendment.
Investor Verification Checklist
- Verify the specific terms of the modified capital expenditure and capital lease covenants in the Fourth Amendment (Exhibit 10.1).
- Confirm the total outstanding debt balance and interest rates under the amended Credit Agreement.
- Review subsequent filings to determine if the covenant changes resulted in increased capital spending.
- Check for any related press releases or 10-Q/10-K filings that provide context on the company's liquidity needs prompting this amendment.